Clopidogrel is a prodrug that is converted by CYP2C19 to the active metabolite that inhibits platelet functions and has
Posted: Thu Sep 16, 2021 4:33 am
Clopidogrel is a prodrug that is converted by CYP2C19 to the
active metabolite that inhibits platelet functions and has
antithrombotic effect. A common dose-dependent adverse effect
associated with antiplatelet agents is bleeding. Predict the effect
of CYP2C19*17/*17 genotype on bleeding risk in a patient taking
clopidogrel.
active metabolite that inhibits platelet functions and has
antithrombotic effect. A common dose-dependent adverse effect
associated with antiplatelet agents is bleeding. Predict the effect
of CYP2C19*17/*17 genotype on bleeding risk in a patient taking
clopidogrel.